Q32 Bio (Phase 2 Complement Inhibitor Adx-097) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Q32 Bio (Phase 2 Complement Inhibitor Adx-097) General Information
Description
A phase 2 drug intended to cure rare kidney disease
Contact Information
Corporate Office
- Waltham, MA
- United States
Corporate Office
- Waltham, MA
- United States
Q32 Bio (Phase 2 Complement Inhibitor Adx-097) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Q32 Bio (Phase 2 Complement Inhibitor Adx-097) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Q32 Bio (Phase 2 Complement Inhibitor Adx-097) FAQs
-
Where is Q32 Bio (Phase 2 Complement Inhibitor Adx-097) headquartered?
Q32 Bio (Phase 2 Complement Inhibitor Adx-097) is headquartered in Waltham, MA.
-
What industry is Q32 Bio (Phase 2 Complement Inhibitor Adx-097) in?
Q32 Bio (Phase 2 Complement Inhibitor Adx-097)’s primary industry is Buildings and Property.
-
Is Q32 Bio (Phase 2 Complement Inhibitor Adx-097) a private or public company?
Q32 Bio (Phase 2 Complement Inhibitor Adx-097) is a Private company.
-
What is the current valuation of Q32 Bio (Phase 2 Complement Inhibitor Adx-097)?
The current valuation of Q32 Bio (Phase 2 Complement Inhibitor Adx-097) is .
-
What is Q32 Bio (Phase 2 Complement Inhibitor Adx-097)’s current revenue?
The current revenue for Q32 Bio (Phase 2 Complement Inhibitor Adx-097) is .
-
Who are Q32 Bio (Phase 2 Complement Inhibitor Adx-097)’s investors?
Q32 Bio has invested in Q32 Bio (Phase 2 Complement Inhibitor Adx-097).
-
When was Q32 Bio (Phase 2 Complement Inhibitor Adx-097) acquired?
Q32 Bio (Phase 2 Complement Inhibitor Adx-097) was acquired on 01-Dec-2024.
-
Who acquired Q32 Bio (Phase 2 Complement Inhibitor Adx-097)?
Q32 Bio (Phase 2 Complement Inhibitor Adx-097) was acquired by Akebia Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process